HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$35.33
Day range
$34.52 - $35.59
Year range
$12.91 - $37.50
Market cap
3.13B USD
Avg Volume
1.91M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 164.86M | 162.11% |
Operating expense | 86.45M | 31.75% |
Net income | 25.71M | 146.90% |
Net profit margin | 15.59 | 117.89% |
Earnings per share | 0.59 | 228.26% |
EBITDA | 40.72M | 190.92% |
Effective tax rate | 0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 254.53M | -8.26% |
Total assets | 538.58M | 6.77% |
Total liabilities | 465.02M | -13.06% |
Total equity | 73.56M | — |
Shares outstanding | 89.47M | — |
Price to book | 43.09 | — |
Return on assets | 11.40% | — |
Return on capital | 14.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 25.71M | 146.90% |
Cash from operations | 14.32M | 133.68% |
Cash from investing | 86.59M | 87.73% |
Cash from financing | -65.34M | -142,141.30% |
Net change in cash | 35.78M | 768.77% |
Free cash flow | -16.59M | 43.50% |
About
Founded
2008
Website
Employees
385
